Article
Prevalence and clinico-genomic characteristics of patients with TRK fusion cancer in China
11 Aug 2023
Abstract excerpt
Neurotrophic tyrosine kinase (NTRK) fusions involving NTRK1, NTRK2, and NTRK3 were found in a broad range of solid tumors as driver gene variants. However, the prevalence of NTRK fusions in Chinese solid tumor patients is rarely reported. Based on the next-generation sequencing data from 10,194 Chinese solid tumor patients, we identified approximately 0.4% (40/10,194) of Chinese solid tumor patients with NTRK...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
